Perspective: Recommendations for benchmarking pre-clinical studies of nanomedicines

類似資料

• Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments
  著者:: Dawidczyk, Charlene M., 等
  出版事項: (2014)
• State-of-the-Art in Design Rules for Drug Delivery Platforms: Lessons from FDA-approved Nanomedicines
  著者:: Dawidczyk, Charlene M., 等
  出版事項: (2014)
• Tumor accumulation of liposomal doxorubicin in three murine models: optimizing delivery efficiency
  著者:: Dawidczyk, Charlene M., 等
  出版事項: (2017)
• Clinical Translation of Nanomedicine
  著者:: Min, Yuanzeng, 等
  出版事項: (2015)
• Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies
  著者:: Borges, Gabriel Silva Marques, 等
  出版事項: (2021)